Preventive and/or therapeutic agent for calcipenia

Details Preventive and/or therapeutic agent for calcipenia Preventive and/or therapeutic agent for calcipenia

2004-08-13

2011-11-01

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

Reexamination Certificate

active

08048866

ABSTRACT:
The invention is to develop an agent having at least one of anticalcipenic, antiedemic and diuretic activities for humans or animals and to inhibit the postpartum drop of the calcium concentration in blood, thereby maintaining the health of the mother body and smoothing nursing and lactation.In the invention, difructose anhydride (DFA) being a disaccharide made of two molecules of fructose coupled together is administered. In particular, for inhibiting the postpartum drop of the calcium concentration in blood, DFA III and/or DFA IV is administered before childbirth delivery (in a cow, before an expected date of calving). The joint use of a calcium agent or vitamin D is possible as required.

REFERENCES:
patent: 63 269962 (1988-11-01), None
patent: 63-269962 (1988-11-01), None
patent: 1-285195 (1989-11-01), None
patent: 5-168419 (1993-07-01), None
patent: 5 168419 (1993-07-01), None
patent: 5-279377 (1993-10-01), None
patent: 11 43438 (1999-02-01), None
patent: 11-43438 (1999-02-01), None
patent: 11-155520 (1999-06-01), None
patent: 11-155564 (1999-06-01), None
patent: 2000-60541 (2000-02-01), None
patent: 2000-204042 (2000-07-01), None
patent: 2000 204042 (2000-07-01), None
patent: 2002-68970 (2002-03-01), None
patent: 2003-321371 (2003-11-01), None
patent: 3514955 (2004-01-01), None
patent: 2004-329110 (2004-11-01), None
patent: 03 090759 (2003-11-01), None
Mitamura R. and Hara, H. and Aoyama, Y. and Chiji, H., Journal of Nutrition, Supplemental Feeding of Difructose Anhydride III Restores Calcium Absorption Impaired by Ovariectomy in Rats, (2002), vol. 132, pp. 3387-3393.
WordNet Search 3.0 “prevent”; also availale at http://wordnetweb.princeton.edu/perl/webwn; last viewed Nov. 14, 2007.
Shigematsu, N. et al., Biosc. Biotechnol. Biochem. “Effect of Difructose Anhydride III on Calcium Absorption in Humans”, vol. 68, issue 5, pp. 1011-1016 (Jan. 2004).
Sowers, M. F., Journal of the American Medical Association, “Changes in Bone Density with Lactation”, vol. 269, pp. 3130-3135 (1993).
Goff, J. P., The Veterinary Clinics of North America: Food Animal Practice, “Pathophysiology of calcium and phosphorous disorders”, vol. 16, issue 2, pp. 319-337, vii; Jul. 2000.
USDA, “National Organic Program, Dry Matter Demand Tables for Classes of Dairy Cattle”; also available at www.ams.usda.gov
op or http://www.ams.usda.gov/AMSv1.0/getfile?dDocName=STELPRDC5082662&acct=noprulemaking; published Mar. 2010.
Tadashi Sato, et al. “Effect of Ruminal Bacteria on Degradability of Difructose Anhydride III”, Animal Science Journal, vol. 77, No. 3, Aug. 2006, pp. 395-399 (with English abstract).
Tadashi Sato, et al. “Effect of Difructose Anhydride III on Hypocalcemia in Dairy Cows After Calving”, Animal Science Journal, vol. 78, No. 1, Feb. 2007, pp. 37-43 (with English abstract).
Tadashi Sato, et al., The Lecture Abstract Book of the 104thGeneral Meeting of Japanese Society of Animal Science, Mar. 2005, (with English abstract).
Takuya Suzuki, et al. “Effects of Difructose Anhydride III on Calcium Absorption in Small and Large Intestines of Rats”, Biosci. Biotechnol. Biochem., vol. 62, No. 5, 1998, pp. 837-841.
Katsuichi Saito, et al. “Effects of DFA IV in Rats: Calcium Absorption and Metabolism of DFA IV by Intestinal Microorganisms”. Biosci. Biotechnol. Biochem., vol. 63, No. 4, 1999, pp. 655-661.
Hitoshi Mineo, et al. “Various Indigestible Saccharides Enhance Net Calcium Transport From the Epithelium of the Small and Large Intestine of Rats in Vitro”, The Journal of Nutrition, vol. 131, No. 12, 2001, pp. 3243-3246.
Christopher S. Kovacs, “Calcium and Bone Metabolism in Pregnancy and Lactation”, The Journal of Clinical Endocrinology and Metabolism, vol. 86, No. 6, XP002571142, Jun. 2001, pp. 2344-2348.

Affiliated with

Also associated with

Rating

Preventive and/or therapeutic agent for calcipenia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Preventive and/or therapeutic agent for calcipenia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preventive and/or therapeutic agent for calcipenia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4278207